Arca Biopharma | ABIO - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 20.83B 17.97B 2026-09
Arca Biopharma USD 6.67M 2.5M 2026-03
Biogen USD 430.3M 26.4M 2026-09
Brainstorm Cell Therapeutics USD 7.49M 171K 2026-06
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Capricor Therapeutics 3.05M 31.77K 2026-09
Cipla INR 32.66B 361.1M 2026-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.15M 371K 2026-06
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 25.96M 5.45M 2026-09
Daiichi Sankyo JPY 612.24B 73.19B 2026-09
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Grifols EUR 987.75M 47.87M 2025-12
Laboratory Of America USD 738M 49.5M 2026-09
Myriad Genetics USD 30.4M 2.2M 2026-06
Otsuka Holdings JPY 199.81B 16.83B 2026-09
Pfizer USD 4.07B 511M 2026-09
United Therapeutics USD 520.2M 22.4M 2026-09